The Value of a Second Transurethral Resection in Evaluating Patients with Bladder Tumours

By Miladi M.   Peyromaure M.   Zerbib M.   Saghi D.   Debre B.  

European Urology, Vol. 43, Iss. 3, 2003-03 ,pp. : 241-245

Elsevier

Access to resources Recommend Favorite

Lymphocyte subpopulations: prognostic value of patients with renal cell carcinoma under therapy with IL-2 and IFN-alpha

By Hillig F.   Schneider T.   Zacharias M.   Langner J.   Fornara P.  

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 141-141

Elsevier

Access to resources Recommend Favorite

Challenges in the diagnosis and management of musculoskeletal tumours in Nigeria

By Eyesan S.  

International Orthopaedics, Vol. 33, Iss. 1, 2009-02 ,pp. : 211-213

Springer Publishing Company

Access to resources Recommend Favorite

Analysis of clinical characteristics, management and survival of patients with Ta T1 bladder tumours in Sweden between 1997 and 2001

By Gårdmark Truls   Bladström Anna   Hellsten Sverker   Malmström Per-Uno   OF THE SWEDISH NATIONAL BLADDER CANCER REGISTRY MEMBERS  

Scandinavian Journal of Urology and Nephrology, Vol. 40, Iss. 4, 2006-09 ,pp. : 276-282

Informa Healthcare

Access to resources Recommend Favorite

Correlation between inflammatory cells (T and B lymphocytes, macrophages) in prostate biopsies and elevated PSA levels in a PSA screening population

By Moser P.L.   Brunner A.   Horninger W.   Bartsch G.   Mikuz G.  

Urology, Vol. 59, Iss. 1, 2002-01 ,pp. : 68-72

Elsevier

Access to resources Recommend Favorite